| Cvs Pharmacy #48364 | |
| 4800 Fillmore Ave, Alexandria, Virginia 22311 | |
| (703) 820-1061 |
| Name | Cvs Pharmacy #48364 |
|---|---|
| Organization Name | Main Street Pharmacy, Llc |
| Location | 4800 Fillmore Ave, Alexandria, Virginia 22311 |
| Type | Long Term Care Pharmacy |
| Phone | (703) 820-1061 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
Researchers at the University of Alabama at Birmingham are developing and testing a new peptide that they hope will lead to better treatment options for familial hypercholesterolemia.
A study by six researchers, including a University of Colorado at Boulder associate professor and his former doctoral student, shows that amputees who use running-specific prosthetic legs have no performance advantage over counterparts who use their biological legs.
› Verified 2 days ago
| NPI Number | 1942300223 |
| Organization Name | MAIN STREET PHARMACY, LLC |
| Doing Business As | CVS PHARMACY #48364 |
| Type | Long Term Care Pharmacy |
| Address | 4800 Fillmore Ave, Alexandria, VA 22311 |
| Phone Number | 703-824-1352 |
News Archive
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
Researchers at the University of Alabama at Birmingham are developing and testing a new peptide that they hope will lead to better treatment options for familial hypercholesterolemia.
A study by six researchers, including a University of Colorado at Boulder associate professor and his former doctoral student, shows that amputees who use running-specific prosthetic legs have no performance advantage over counterparts who use their biological legs.
› Verified 2 days ago
News Archive
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
Researchers at the University of Alabama at Birmingham are developing and testing a new peptide that they hope will lead to better treatment options for familial hypercholesterolemia.
A study by six researchers, including a University of Colorado at Boulder associate professor and his former doctoral student, shows that amputees who use running-specific prosthetic legs have no performance advantage over counterparts who use their biological legs.
› Verified 2 days ago
Aeroflow Urology, Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2616 Sherwood Hall Ln, Alexandria, Virginia 22306 Phone: (888) 345-1780 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5705 General Washington Dr, Alexandria, Virginia 22312 Phone: (703) 642-3141 | |
Giant Pharmacy #232 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5870 Kingstowne Ctr, Alexandria, Virginia 22315 Phone: (703) 313-8092 | |
Giant Pharmacy #261 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3131 Duke St, Alexandria, Virginia 22314 Phone: (703) 461-6199 | |
Giant Pharmacy #2742 Type: Medicare Supplier Location: 621e Glebe Rd, Alexandria, Virginia 22305 Phone: (703) 299-0471 |